MMC
LAB icon

MDV Management Company’s Standard BioTools LAB Stock Holding History

MDV Management Company’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.42M Buy
+71,675
New +$2.03M 0.82% 5

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MDV Management Company's LAB Position: Q4 2014 in Review

MDV Management Company opened a new position in Standard BioTools (LAB) in Q4 2014: 71,675 shares worth $2.42M. The stake represents 0.82% of the portfolio and ranks #5 among its holdings.

100 funds tracked by Wall St. Rank hold LAB as of Q4 2014.

  • MDV Management Company held 71,675 shares of Standard BioTools worth $2.42M as of Q4 2014.
  • Standard BioTools was a new MDV Management Company position in Q4 2014.
  • Standard BioTools made up 0.82% of MDV Management Company's portfolio in Q4 2014, its #5 holding.
  • 100 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2014.

Based on MDV Management Company's 13F filing for Q4 2014, filed 17 Feb 2015.